Novavax’s COVID-19 vaccine 96.4 per cent effective against virus in phase-3 trial
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
A proxy war is being waged in Sudan taking a heavy toll of human lives and leaving behind a trail...
Read moreDetails
In a move that has stunned world leaders and alarmed non-proliferation experts, US President Donald Trump announced that he has...
Read moreDetails
Aakar Patel I walk out of my house and onto the street and look around. Not much is different from...
Read moreDetails
Syed Ali Murtaza Rizvi’s decision to hang up his boots eight years ahead of time has clearly rattled the Telangana...
Read moreDetails